Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana

Virus Research

Volumn 244, Issue , 2018, Pages 213-217

  Veerapen, Varusha Pillay ^a   van Zyl, Albertha R ^a   Wigdorovitz, Andrés ^c   Rybicki, Edward P ^a,b   Meyers, Ann E ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA   (Argentina)

Author keywords

Capsid proteins; Foot and mouth disease virus; Nicotiana benthamiana; Vaccines; Virus like particles

Indexed keywords

CAPSID PROTEIN; CAPSID PROTEIN VP0; POLYPROTEIN; PROTEIN VP1; PROTEIN VP3; PROTEINASE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; 3C PROTEASES; CYSTEINE PROTEINASE; EPITOPE; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; VIRAL PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

ARTICLE; FOOT AND MOUTH DISEASE VIRUS; IMMUNOGENICITY; MOUSE; NICOTIANA BENTHAMIANA; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS LIKE AGENT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; FEMALE; FOOT AND MOUTH DISEASE; GENETICS; IMMUNIZATION; IMMUNOLOGY; METABOLISM; SUBCUTANEOUS DRUG ADMINISTRATION; TOBACCO; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CYSTEINE ENDOPEPTIDASES; EPITOPES; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; TOBACCO; VACCINES, VIRUS-LIKE PARTICLE; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 85035787990     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2017.11.027     Document Type: Article

References (23)

1. Abrams, C.C., King, A.M., Belsham, G.J., Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 76:Pt 12 (1995), 3089–3098.
2. Birtley, J.R., Knox, S.R., Jaulent, A.M., Brick, P., Leatherbarrow, R.J., Curry, S., Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 280 (2005), 11520–11527.
3. Cao, Y., Lu, Z., Sun, J., Bai, X., Sun, P., Bao, H., Chen, Y., Guo, J., Li, D., Liu, X., et al. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Vet. Microbiol. 137 (2009), 10–17.
4. Dus Santos, M.J., Wigdorovitz, A., Transgenic plants for the production of veterinary vaccines. Immunol. Cell Biol. 83 (2005), 229–238.
5. Dus Santos, M.J., Carrillo, C., Ardila, F., Rios, R.D., Franzone, P., Piccone, M.E., Wigdorovitz, A., Borca, M.V., Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 23 (2005), 1838–1843.
6. Duwadi, K., Chen, L., Menassa, R., Dhaubhadel, S., Identification, characterization and down-Regulation of cysteine protease genes in tobacco for use in recombinant protein production. PLoS One, 10, 2015, e0130556.
7. Guo, H.-C., Sun, S.-Q., Jin, Y., Yang, S.-L., Wei, Y.-Q., Sun, D.-H., Yin, S.-H., Ma, J.-W., Liu, Z.-X., Guo, J.-H., et al. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Vet. Res., 44, 2013 (48-48).
8. Hao, L., Hsiang, T., Goodwin, P.H., Role of two cysteine proteinases in the susceptible response of Nicotiana benthamiana to Colletotrichum destructivum and the hypersensitive response to Pseudomonas syringae pv. tomato. Plant Sci. 170 (2006), 1001–1009.
9. Huang, H., Yang, Z., Xu, Q., Sheng, Z., Xie, Y., Yan, W., You, Y., Sun, L., Zheng, Z., Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine. Viral Immunol. 12 (1999), 1–8.
10. Kushnir, N., Streatfield, S.J., Yusibov, V., Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31 (2012), 58–83.
11. Lewis, S.A., Morgan, D.O., Grubman, M.J., Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 65 (1991), 6572–6580.
12. Li, Z., Yi, Y., Yin, X., Zhang, Y., Liu, M., Liu, H., Li, X., Li, Y., Zhang, Z., Liu, J., Development of a foot-and-mouth disease virus serotype a empty capsid subunit vaccine using silkworm (Bombyx mori) pupae. PLoS One, 7, 2012, e43849.
13. Marsian, J., Fox, H., Bahar, M.W., Kotecha, A., Fry, E.E., Stuart, D.I., Macadam, A.J., Rowlands, D.J., Lomonossoff, G.P., Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine. Nat. Commun., 8, 2017, 245.
14. Mateo, R., Luna, E., Rincon, V., Mateu, M.G., Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. J. Virol. 82 (2008), 12232–12240.
15. Mignaqui, A.C., Ruiz, V., Perret, S., St-Laurent, G., Singh Chahal, Transfiguracion, J., Sammarruco, A., Gnazzo, V., Durocher, Y., Wigdorovitz, A., Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids. PLoS One, 8, 2013, e72800.
16. Porta, C., Kotecha, A., Burman, A., Jackson, T., Ren, J., Loureiro, S., Jones, I.M., Fry, E.E., Stuart, D.I., Charleston, B., Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen. PLoS Pathog., 9, 2013, e1003255.
17. Porta, C., Xu, X., Loureiro, S., Paramasivam, S., Ren, J., Al-Khalil, T., Burman, A., Jackson, T., Belsham, G.J., Curry, S., et al. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity. J. Virol. Methods 187 (2013), 406–412.
18. Puckette, M., Clark, B.A., Smith, J.D., Turecek, T., Martel, E., Gabbert, L., Pisano, M., Hurtle, W., Pacheco, J.M., Barrera, J., et al. Foot-and-mouth disease (FMD) virus 3C protease mutant L127P: implications for FMD vaccine development. J. Virol., 91, 2017.
19. Robinson, L., Knight-Jones, T.J., Charleston, B., Rodriguez, L.L., Gay, C.G., Sumption, K.J., Vosloo, W., Global foot-and-mouth disease research update and gap analysis: 3 – vaccines. Transbound. Emerg. Dis. 63:Suppl. 1 (2016), 30–41.
20. Roosien, J., Belsham, G.J., Ryan, M.D., King, A.M., Vlak, J.M., Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 71:Pt 8 (1990), 1703–1711.
21. Sainsbury, F., Thuenemann, E.C., Lomonossoff, G.P., pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 7 (2009), 682–693.
22. Xiao, Y., Chen, H.-Y., Wang, Y., Yin, B., Lv, C., Mo, X., Yan, H., Xuan, Y., Huang, Y., Pang, W., et al. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. BMC Biotechnol., 16, 2016, 56.
23. Zunszain, P.A., Knox, S.R., Sweeney, T.R., Yang, J., Roque-Rosell, N., Belsham, G.J., Leatherbarrow, R.J., Curry, S., Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. J. Mol. Biol. 395 (2010), 375–389.